Ensysce Biosciences ENSC
NASDAQ ENSC
$0.52 +0.00 (+0.00%)
As of: Oct 22, 2026 · 1:15 PM EDT

Ensysce Biosciences (ENSC) Other financing activities (2018 - 2019)

Updated

Ensysce Biosciences' Other financing activities was $20.00 in FY2020, down 99.8% from $8,640 in FY2019.

Analysis

Ensysce Biosciences (ENSC) Other financing activities (2018 - 2019) Analysis & Trends

  • Per Business Quant data, Other financing activities in earlier years was $8,640 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.37 Bn 1,134.95 Bn 19.71 Bn
2 Johnson & Johnson 643.27 Bn 563.13 Bn 17.30 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 358.37 Bn 312.75 Bn 12.21 Bn
5 Novartis Ag 301.91 Bn 265.90 Bn 11.24 Bn
6 Astrazeneca 267.33 Bn 241.01 Bn 12.86 Bn
7 Amgen 241.44 Bn 196.84 Bn 7.24 Bn
8 Gilead Sciences 193.00 Bn 167.20 Bn 6.22 Bn
9 Pfizer 171.57 Bn 118.21 Bn 10.94 Bn
10 Ensysce Biosciences 1.33 Mn -9.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -8,640.00
Mar 31, 2018 -32,000.00
API Access

Ensysce Biosciences Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ENSC&period=max&api_key=YOUR_API_KEY